Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Clin Genitourin Cancer. 2018 Jul 12;16(6):421–428.e1. doi: 10.1016/j.clgc.2018.07.004

Table 2.

Summary of Grade >3 Adverse Events

Adverse Event Arm A (n = 6)
Arm B (n = 6)
n % n %
Anemia 3 50 3 50
Diarrhea 0  0 1 17
Injection Site Reaction 0  0 1 17
Fatigue 6 100 0  0
Edema Limbs 0  0 2 33
Sepsis 2  33 0  0
Lymphocyte Count Decreased 0  0 1 17
Lymphocyte Count Increased 0  0 2 33
Neutrophil Count Decreased 2 33 1 17
White Blood Cell Count Decreased 2  33 0  0
Platelet Count Decreased 0  0 1 17
Hyponatremia 2  33 2 33
Hypophosphatemia 2  33 0  0
Hypoalbuminemia 0  0 2 33
Rash, Maculopapular 1  17 0  0